EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Analysis of DBS Outcome by MDS ‐ UPDRS Severity Levels: Comparison with Changes on MDS ‐ UPDRS III

Sergio A Castillo-Torres iD, Ivonne Cruz, Malco Rossi, Miguel Wilken, Daniel Cerquetti, Marcelo Merello iD

Movement Disorders Clinical Practice · 2025

DOI: 10.1002/mdc3.70244 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von Sergio A Castillo-Torres und 5 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Movimientos Anormales, Departamento de Neurología, Fleni, Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Parkinson Disease, Severity of Illness Index, Subthalamic Nucleus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

MDS‐UPDRS Severity Levels (SLs), derived from clinician‐ and patient‐rated scales, remain underused to evaluate response to subthalamic deep brain stimulation (STN‐DBS) in patients with Parkinson's disease (PD).

Objectives

To evaluate MDS‐UPDRS SL as markers of STN‐DBS response.

Methods

SLs were categorized as mild, moderate, or severe using established cut‐off points for Parts II, III Off, and IV. Improvement was defined as a decrease in at least one SL. Part III Off improvement was correlated to quality‐of‐life scales and used to predict SL improvement using ROC Curve analysis.

Results

A total of 51 patients (34.1% female, aged 58.9 ± 10.2 years, disease duration 12.3 ± 4.1 years) were evaluated 12 months after surgery. MDS‐UPDRS III Off changes over 30% predicted SL improvements in MDS‐UPDRS II (AUC = 0.83, p = 0.015) and IV (AUC = 0.89, p = 0.001).

Conclusion

Our findings suggest that improvement in MDS‐UPDRS SL are potential markers of STN‐DBS response. With an MDS‐UPDRS part III improvement around 30% predicting SL improvement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep Brain StimulationParkinson DiseaseSeverity of Illness IndexSubthalamic NucleusHumansFemaleMiddle AgedMaleAgedTreatment OutcomeQuality of Life

Stichwörter der Autor:innen

MDS‐UPDRSParkinson's diseaseSTN‐DBSdeep brain stimulationtreatment outcome

Autor:innen und Institutionen

  • Servicio de Movimientos Anormales, Departamento de Neurología, Fleni, Buenos Aires, Argentina.
  • Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
  • Servicio de Neurofisiología Clínica, Departamento de Neurología, Fleni, Buenos Aires, Argentina.
  • Facultad de Ciencias Médicas, Pontificia Universidad Católica Argentina, Buenos Aires, Argentina.

ORCID-Profile: Sergio A Castillo-Torres, Marcelo Merello

Zitieren

APA

Castillo-Torres, S. A., Cruz, I., Rossi, M., Wilken, M., Cerquetti, D., & Merello, M. (2025). Analysis of DBS Outcome by MDS ‐ UPDRS Severity Levels: Comparison with Changes on MDS ‐ UPDRS III. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70244

Vancouver

Castillo-Torres SA, Cruz I, Rossi M, Wilken M, Cerquetti D, Merello M. Analysis of DBS Outcome by MDS ‐ UPDRS Severity Levels: Comparison with Changes on MDS ‐ UPDRS III. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.70244

BibTeX
@article{CastilloTorres2025,
  author = {Castillo-Torres, Sergio A and Cruz, Ivonne and Rossi, Malco and Wilken, Miguel and Cerquetti, Daniel and Merello, Marcelo},
  title = {Analysis of DBS Outcome by MDS ‐ UPDRS Severity Levels: Comparison with Changes on MDS ‐ UPDRS III},
  journal = {Movement Disorders Clinical Practice},
  year = {2025},
  doi = {10.1002/mdc3.70244}
}
Kostenlos starten →